Randomized, double blind placebo-controlled studies to evaluate the safety and tolerability of a novel Llama-derived anti-rotavirus VHH fragment in human volunteers (Part-I), and its therapeutic efficacy in children with rotavirus diarrhoea (Part-II)
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sarker, Shafiqul A. | - |
dc.date.accessioned | 2014-06-24T08:45:00Z | - |
dc.date.available | 2014-06-24T08:45:00Z | - |
dc.date.issued | 2004 | - |
dc.identifier.uri | http://hdl.handle.net/123456789/5126 | - |
dc.format.extent | 753664 bytes | - |
dc.format.mimetype | application/msword | - |
dc.language.iso | en | en |
dc.publisher | Dhaka: International Centre for Diarrhoeal Diseases Research, Bangladesh; 2004 | en |
dc.relation.ispartofseries | icddrb research protocol no. 2004-009 | en |
dc.subject | Clinical protocols | en |
dc.subject | Rotavirus | en |
dc.subject | Diarrhoeal, infantile | en |
dc.title | Randomized, double blind placebo-controlled studies to evaluate the safety and tolerability of a novel Llama-derived anti-rotavirus VHH fragment in human volunteers (Part-I), and its therapeutic efficacy in children with rotavirus diarrhoea (Part-II) | en |
dc.type | Other | en |
Appears in Collections: | Clinical sciences research protocols |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ICDDRBProtocol-2004-009.doc | 736 kB | Microsoft Word | View/Open |
This item is protected by original copyright |